1. DEAD-ly Affairs: The Roles of DEAD-Box Proteins on HIV-1 Viral RNA Metabolism
    Shringar Rao et al, 2022, Frontiers in Cell and Developmental Biology CrossRef
  2. The RNA helicase DDX3 induces neural crest by promoting AKT activity
    Mark Perfetto et al, 2020, Development CrossRef
  3. PHGDH Is Upregulated at Translational Level and Implicated in Platin-Resistant in Ovarian Cancer Cells
    Fangfang Bi et al, 2021, Frontiers in Oncology CrossRef
  4. Integrated Analysis of DEAD-Box Helicase 56: A Potential Oncogene in Osteosarcoma
    Chen Zhu et al, 2020, Frontiers in Bioengineering and Biotechnology CrossRef
  5. Interactions of the C-Terminal Truncated DEAD-Box Protein DDX3X With RNA and Nucleotide Substrates
    Anthony F. T. Moore et al, 2021, ACS Omega CrossRef
  6. Research progress in molecular pathology markers in medulloblastoma
    Zixuan Zhou et al, 2023, Exploration of Targeted Anti-tumor Therapy CrossRef
  7. Saturation genome editing of DDX3X clarifies pathogenicity of germline and somatic variation
    Elizabeth J. Radford et al, 2023, Nature Communications CrossRef
  8. Cytoplasmic DDX3 as prognosticator in male breast cancer
    Carmen C. van der Pol et al, 2021, Virchows Archiv CrossRef
  9. Non-BRAF Mutant Melanoma: Molecular Features and Therapeutical Implications
    Irene Vanni et al, 2020, Frontiers in Molecular Biosciences CrossRef
  10. Novel Butein Derivatives Repress DDX3 Expression by Inhibiting PI3K/AKT Signaling Pathway in MCF-7 and MDA-MB-231 Cell Lines
    Shailima Rampogu et al, 2021, Frontiers in Oncology CrossRef
  11. Broad genomic workup including optical genome mapping uncovers a DDX3X: MLLT10 gene fusion in acute myeloid leukemia
    Verena Nilius-Eliliwi et al, 2022, Frontiers in Oncology CrossRef
  12. The human DEAD-box helicase DDX3X as a regulator of mRNA translation
    Cathal S. Ryan et al, 2022, Frontiers in Cell and Developmental Biology CrossRef
  13. Molecular docking, synthesis, and biological evaluation of 7-azaindole-derivative (7AID) as novel anti-cancer agent and potent DDX3 inhibitor:—an in silico and in vitro approach
    Ravinder Doneti et al, 2022, Medical Oncology CrossRef
  14. Prokaryotic Expression and Affinity Purification of DDX3 Protein
    Lan Huang et al, 2024, Protein & Peptide Letters CrossRef